Member Spotlights
Our Member Spotlights series highlights the remarkable organizations that make up our consortium and the unique value they bring. Explore our latest features below to learn more about their work and what they’re seeking in potential partnerships.
Spotlight Article
Previous Spotlights
| Member Name | Spotlight Article | Date Posted |
|---|---|---|
| Curi Bio | Read the Spotlight Here | 5/27/26 |
| Member Name | Spotlight Article | Date Posted |
|---|---|---|
| Sapphiros | Read the Spotlight Here | 10/9/25 |
| Unicorn Biotechnologies | Read the Spotlight Here | 10/9/25 |
| PharmaJet | Read the Spotlight Here | 11/18/25 |
| BRCR Global | Read the Spotlight Here | 11/18/25 |
| Zymeron Corporation | Read the Spotlight Here | 12/15/25 |
| FABimation, Inc. | Read the Spotlight Here | 1/12/26 |
| Silverstream Medical | Read the Spotlight Here | 2/19/26 |
The Rapid Response Partnership Vehicle Consortium Awards Project to Sapphiros for Biothreat Diagnostics Initiative
Sapphiros was awarded approximately $12.4 million to advance rapid molecular diagnostictesting options for tularemia, Nipah virus, and Hendra virus
The RRPV Roundup – June
Our biannual e-newsletter, The RRPV Roundup, is designed to keep you updated on consortium highlights, opportunities, upcoming events, and more.
The RRPV Roundup – October
Our biannual e-newsletter, The RRPV Roundup, is designed to keep you updated on key milestones, highlight members, and share relevant opportunities across the consortium.
The Rapid Response Partnership Vehicle Consortium Awards an Additional Project for its Biothreat Diagnostics Initiative
Aptitude Medical Systems, Inc. was awarded approximately $9 million to further advance Ebola virus and Marburg virus testing options.
Rapid Response Partnership Vehicle Makes First Awards for Biothreat Diagnostics
The Rapid Response Partnership Vehicle Consortium made its first awards under the Diagnostics Rapid Response Initiative, a biothreat diagnostics program that supports the development of medical tools, equipment, and devices used to diagnose diseases caused by biothreats.
The Rapid Response Partnership Vehicle Celebrates its First Year
Over the past year, RRPV has evolved into a robust consortium of dedicated members committed to advancing the research and development of future medical countermeasure products.